| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44028560 | HTLV-1 | ENSG00000197081.16 | protein_coding | IGF2R | No | No | 3482 | P11717 |
| TVIS44007834 | HTLV-1 | ENSG00000197081.16 | protein_coding | IGF2R | No | No | 3482 | P11717 |
| TVIS44033036 | HTLV-1 | ENSG00000197081.16 | protein_coding | IGF2R | No | No | 3482 | P11717 |
| TVIS44039094 | HTLV-1 | ENSG00000197081.16 | protein_coding | IGF2R | No | No | 3482 | P11717 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | IGF2R |
|---|---|
| DrugBank ID | DB13173 |
| Drug Name | Cerliponase alfa |
| Target ID | BE0003623 |
| UniProt ID | P11717 |
| Regulation Type | ligand |
| PubMed IDs | 22792360 |
| Citations | Meng Y, Sohar I, Wang L, Sleat DE, Lobel P: Systemic administration of tripeptidyl peptidase I in a mouse model of late infantile neuronal ceroid lipofuscinosis: effect of glycan modification. PLoS One. 2012;7(7):e40509. doi: 10.1371/journal.pone.0040509. Epub 2012 Jul 6. |
| Groups | Approved; Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL3544921 |
